Sources
 GE HealthCare Unveils Head-Only MRI Scanner for Advanced Neuroscience Research
HIT Consultant - (Monday May 6, 2024) What You Should Know: – GE HealthCare announced the unveiling of SIGNA MAGNUS, a revolutionary head-only magnetic resonance imaging (MRI) scanner. – This FDA 510(k) pending technology holds immense promise for unlocking new frontiers in neuroscience…  RapidAI Scores FDA Clearance, Bringing AI-Powered Stroke Assessment to the Interventional Suite
HIT Consultant - (Monday May 6, 2024) What You Should Know: – RapidAI, a global leader in AI-powered solutions for combating life-threatening vascular diseases, announced today the FDA 510(k) clearance for its innovative AngioFlow™ by RapidAI solution. – The technology empowers interventional care… |
 Precision medicine tool predicts breast cancer immunotherapy response
Health IT Analytics - (Monday May 6, 2024) By Shania Kennedy May 06, 2024 – Researchers from the University of Texas (UT) Southwestern Medical Center have developed a computational tool to predict breast cancer immunotherapy response by analyzing how cancer and immune cells interact.  Curbside Consult with Dr. Jayne 5/6/24 – HIStalk
HIStalk - (Monday May 6, 2024) |
 It’s Time to Rethink Healthcare’s Reliance on Legacy Tech Amid Cyberattacks – HIStalk
HIStalk - (Monday May 6, 2024) It’s Time to Rethink Healthcare’s Reliance on Legacy Tech Amid CyberattacksBy Tom Furr One of the biggest questions surrounding a large-scale cyberattack…  A Chinese Mother’s Memoir, Completed by Her Son
eHealth Radio Network - (Monday May 6, 2024)
Richard Perkins Hsung who has spent ten years editing and completing Spring Flower, by his mother, Jean Tren-Hwa Perkins, MD joins eHealth Radio and the Health News and Mental Health Channels. This three-volume memoir… |
 OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors
HIT Consultant - (Monday May 6, 2024) What You Should Know: – OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing…  The Evaluation of Generative AI Should Include Repetition to Assess Stability
JMIR mHealth and uHealth - (Monday May 6, 2024) The increasing interest in the potential applications of generative artificial intelligence (AI) models like ChatGPT in health care has prompted numerous studies to explore its performance in various medical contexts. However, evaluating ChatGPT poses… |
 Assessing the Efficacy of ChatGPT Versus Human Researchers in Identifying Relevant Studies on mHealth Interventions for Improving Medication Adherence in Patients With Ischemic Stroke When Conducting Systematic Reviews: Comparative Analysis
JMIR mHealth and uHealth - (Monday May 6, 2024) Background: ChatGPT by OpenAI emerged as a potential tool for researchers, aiding in various aspects of research. One such application was the identification of relevant studies in systematic reviews. However, a comprehensive comparison of…  The FDA approves Apple Watch’s heart monitoring tool for use in clinical trials
MobiHealthNews - (Monday May 6, 2024) The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, enabling researchers to use it to detect arrhythmias or… |
